SOURCE: Antisoma plc

June 08, 2007 07:00 ET

Antisoma to present at Needham & Company Sixth Annual Biotechnology Conference on 13 June 2007

LONDON--(Marketwire - June 8, 2007) -


8 June 2007, London, UK - Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that its Chief Executive Officer, Glyn Edwards, will be presenting at the Needham & Company Sixth Annual Biotechnology and Medical Technology Conference in New York, USA.

Mr Edwards's presentation is scheduled for 11am EST on Wednesday, June 13, followed by a 30 minute breakout session. A webcast of the presentation will be available to all on Antisoma's website at www.antisoma.com.

It is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Enquiries:

Katherine Harrison       +44 (0)20 8799 8200
Communications Manager
Antisoma plc

Background on Antisoma

Based in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit www.antisoma.com for further information.

Copyright © Hugin ASA 2007. All rights reserved.

Contact Information